Skip to content
Awesome – Lifestyle
Author:
AEON Biopharma Inc
AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding
July 14, 2026
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society
June 4, 2026
←
Previous Page
1
2